Episode 26: Chris Min, CMO and Interim CEO at Longeveron, Inc.

Episode 26 December 07, 2022 00:39:02
Episode 26: Chris Min, CMO and Interim CEO at Longeveron, Inc.
Few & Far Between: How Biotech Gets Built
Episode 26: Chris Min, CMO and Interim CEO at Longeveron, Inc.

Dec 07 2022 | 00:39:02

/

Show Notes

"Try to find the people who have a really strong background in regulatory science, who really understand the fundamentals, and who you believe can think creatively about the challenges of the cell therapy space." - Chris Min, Longeveron

Biorasi welcomes Chris Min to the Few & Far Between podcast for an inside look at the cell therapy industry and the importance of finding the right team to support your clinical trials. 

Other Episodes

Episode 3

June 09, 2021 00:39:48
Episode Cover

Episode 3: Danielle Drayton, PhD, CEO of REACH Market Research

On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, will be discussing insights into market research solutions for rare...

Listen

Episode 9

September 01, 2021 00:47:27
Episode Cover

Episode 9: Zogenix, Inc.'s Dawn Blessing and J. Michael Graglia from SynGAP

Tune in for today's full episode of Few & Far Between. Episode 9 features Biorasi's Becky Knockemus, Zogenix, Inc.'s Dawn Blessing, and J. Michael...

Listen

Episode 71

May 12, 2026 00:43:24
Episode Cover

Episode 71: Chris O'Brien, Former ⁨Biorasi⁩ CEO and Current CEO of ⁨Rancho Biosciences

Today on the Biorasi Few & Far Between podcast: Join new host Melissa Alesse and former host Chris O'Brien - CEO at Rancho BioSciences...

Listen